Please login to the form below

Not currently logged in
Email:
Password:

US drug prices

This page shows the latest US drug prices news and features for those working in and with pharma, biotech and healthcare.

US politicians round on generics firms for blocking drug pricing probe

US politicians round on generics firms for blocking drug pricing probe

Renews focus on increases in generic drug prices. US politicians are going after Heritage Pharmaceuticals, Mylan and Teva Pharmaceutical Industries for allegedly stonewalling an earlier effort to gather drug pricing information. ... That’s when Elijah

Latest news

More from news
Approximately 12 fully matching, plus 21 partially matching documents found.

Latest Intelligence

  • The Orkambi blame game The Orkambi blame game

    The three-hour evidence session also bore some resemblance to the recent interrogation of seven big pharma CEOs by a US Senate committee enquiry into US drug prices, albeit with just ... were ‘freeloading’ while high US prices provide the incentive

  • Deal Watch October 2018

    US drug prices. In other news from the US, there are now expectations of a legislative stalemate following the mid‐term elections in early November. ... It is worth remembering that there are still a few areas where both political parties are prepared

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    Trump had tweeted days before that Pfizer “should be ashamed that they have raised drug prices for no reason”, claiming they were “taking advantage of the poor and others unable to ... The Trump administration has also just floated the idea of

  • Deal Watch January 2017 Deal Watch January 2017

    bear on US drug prices and the possible revocation of Obamacare in part, if not in full.  In addition, early press coverage suggests that there may be an introduction of a ... 230. Cymabay. Kowa. Exclusive licence in the US. Arhalofenate for gout p3

  • Tracking comms trends: Europe in the global vanguard on value Tracking comms trends: Europe in the global vanguard on value

    But this is changing. President Obama, plus candidates Donald Trump and Hillary Clinton, have all proposed that Medicare should negotiate drug prices. ... More locally, US HMOs and insurance funds are using levels of HTA and deploying cost containment

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics